๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
Non invasive imaging of hypoxia with the aid of PET-scans could help to sel...
Status
Completed
Location
Maastricht Radiation Oncology (MAASTRO clinic)
Start Date
2008-08
Trial ID
NCT00690053
Treatments Being Tested
Regulation of tissue oxygen homeostasis is critical for cell function, prol...
Status
Terminated
Location
MAASTRO Clinic
Start Date
2016-05
Trial ID
NCT02584400
Treatments Being Tested
The aim of this study is to investigate the radiotracer \[18F\]HX4 for non-...
Status
Completed
Location
Nottingham University Hospitals NHS Trust
Start Date
2015-03-31
Trial ID
NCT02976883
Treatments Being Tested
Pancreatic cancer is a highly lethal disease. Patients with resectable or b...
Status
Completed
Location
Academic Medical Center
Start Date
2013-11
Trial ID
NCT01989000
Treatments Being Tested
Several studies have shown that tumour hypoxia may have a negative impact o...
Status
Completed
Location
Academic Medical Center
Start Date
2012-05
Trial ID
NCT01995084
Treatments Being Tested
This pilot phase II study is designed as a test and retest study to investi...
Status
Completed
Location
Multiple Locations
Start Date
2010-02
Trial ID
NCT01075399
Treatments Being Tested
The aim of this study is to (i) Determine if tumor hypoxia can be accuratel...
Status
Completed
Location
Maastricht Radiation Oncology (MAASTRO clinic)
Start Date
2011-12
Trial ID
NCT01347281
Treatments Being Tested
\[F-18\]HX4 is being developed as a diagnostic radiopharmaceutical for PET ...
Status
Completed
Location
Michael Yu, MD
Start Date
2008-01
Trial ID
NCT00606424
Treatments Being Tested
The aim of this study is: 1. to determine if tumor hypoxia can be accurate...
Status
Terminated
Location
MAASTRO clinic
Start Date
2014-11
Trial ID
NCT02233387
Treatments Being Tested